Tanaka, Ryota
Hattori, Nobutaka
Article History
Received: 30 May 2022
Revised: 8 August 2022
Accepted: 25 August 2022
First Online: 20 September 2022
Compliance with ethical standards
:
: RT has received honoraria from Daiichi Sankyo, Bayer, and Eisai. NH has received consulting fees from Hisamitsu Pharma and PARKINSON Laboratories Co., Ltd., received honoraria from Dai-Nippon Sumitomo Pharma, Kyowa Kirin Co., Ltd., Takeda Pharmaceutical, AbbVie GK, Nippon Boehringer Ingelheim, Otsuka Pharmaceutical, Novartis Pharma, Bristol-Myers Squibb, Ono Pharmaceutical, FP Pharmaceutical, Eisai, Kissei Pharmaceutical, Nihon Medi-physics, and Daiichi Sankyo, and received payment for expert testimony from Dai-Nippon Sumitomo Pharma, Kyowa Kirin Co., Ltd., Takeda Pharmaceutical, TEIJIN PHARMA LIMITED, Novartis Pharma, Ono Pharmaceutical, Biogen Idec Japan, Kissei Pharmaceutical, and Mitsubishi Tanabe Pharma and Expert testimony (Honoraria as a team leader) from RIKEN: Center for Brain Science, and stroke ownership and outside the submitted work from PARKINSON Laboratories Co., Ltd.